Today, Bharat Biotech International Limited said that it has completed the clinical development for phase III trials and booster doses for the BBV154 (Covaxin) intranasal Covid-19 vaccine.
#BharatBiotech #IntranasalCovidVaccine #Covaxin bharat biotech,covaxin vaccine bharat biotech,covid vaccine,bharat biotech covaxin phase 3,bharat biotech vaccine,nasal vaccine,bharat biotech nasal vaccine,covaxin bharat biotech,bharat biotech vaccine for coronavirus,phase 3 trial for nasal vaccine almost complete,bharat biotech nasal covid vaccine,covid nasal vaccine bharat biotech,bharat biotech vaccine trialOneindia English, Oneindia News.
